First-in-Human Study of PF-04958242 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance
- Status
- TERMINATED
- Phase
- N/A
Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Natalizumab Treatment of Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Treatment Interruption of Natalizumab
- Status
- COMPLETED
- Phase
- PHASE2
JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab
- Status
- COMPLETED
- Phase
- N/A
JC-Virus (JCV) Antibody Program
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient
- Status
- COMPLETED
- Phase
- PHASE1
A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE3
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
- Status
- COMPLETED
- Phase
- N/A
Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2